Jasper Ridge Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Jasper Ridge Partners’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.2M	Buy	13,845 +8,206	+146%	+$798K	0.03%	88
2025 Q4	$604K	Hold	5,639	–	–	0.01%	99
2025 Q3	$569K	Hold	5,639	–	–	0.01%	105
2025 Q2	$356K	Hold	5,639	–	–	0.01%	117
2025 Q1	$299K	Hold	5,639	–	–	0.01%	116
2024 Q4	$316K	Hold	5,639	–	–	0.01%	114
2024 Q3	$295K	Hold	5,639	–	–	0.01%	117
2024 Q2	$232K	Hold	5,639	–	–	0.01%	126
2024 Q1	$244K	Hold	5,639	–	–	0.01%	126
2023 Q4	$259K	Buy	+5,639	New	+$178K	0.01%	124

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Jasper Ridge Partners's RYTM Position: Q1 2026 in Review

Jasper Ridge Partners increased its Rhythm Pharmaceuticals (RYTM) stake by 146% in Q1 2026, buying an estimated $798K and bringing the position to 13,845 shares worth $1.2M. The position accounts for 0.03% of the portfolio, ranked #88.

Jasper Ridge Partners first reported a position in RYTM in Q4 2023 and has held it in 10 quarters since. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

Jasper Ridge Partners held 13,845 shares of Rhythm Pharmaceuticals worth $1.2M as of Q1 2026.
Jasper Ridge Partners bought 8,206 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $798K.
Rhythm Pharmaceuticals made up 0.03% of Jasper Ridge Partners's portfolio in Q1 2026, its #88 holding.
Jasper Ridge Partners first reported a position in Rhythm Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Jasper Ridge Partners's 13F filing for Q1 2026, filed 11 May 2026.